DiscoverCEimpact PodcastYou Say Yes, I Say Nocebo | GameChangers
You Say Yes, I Say Nocebo | GameChangers

You Say Yes, I Say Nocebo | GameChangers

Update: 2021-01-05
Share

Description

Myopathy is a common reason for discontinuation of statin medications. The recent SAMSON study examined the nocebo effect and how this may bias patients towards treatment failure. How can clinicians overcome the nocebo effect?This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: Wood F, Howard J, Finegold J, et al. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects. N Engl J Med 2020; 383:21 82-2184. DOI: 10.1056/NEJMc2031173See omnystudio.com/listener for privacy information.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

You Say Yes, I Say Nocebo | GameChangers

You Say Yes, I Say Nocebo | GameChangers

Pharmacy Podcast Network